This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Oral Divalproex Sodium Loading for Adolescent Outpatients With Acute Mania/Hypomania: A Report of 2 Cases

John M. Zajecka, MD, and Selika N. Gutierrez, RN, BSN

Published: June 30, 2008

Article Abstract

Letter to the Editor

Sir: Treatment with divalproex sodium delayed release (DR)of the manic phase of bipolar disorder in adults results in rapidclinical response after a therapeutic serum concentration of 50µg/mL is achieved. When divalproex treatment was initiated at750 mg/day and daily dosage was subsequently titrated on thebasis of serial serum divalproex sodium concentration determinations(i.e., a standard titration approach), therapeutic levelsand corresponding antimanic response were observed in mostpatients after 5 to 10 days. In contrast, an oral loading strategyof divalproex sodium 20 mg/kg/day produces serum valproicacid concentrations of approximately 80 µg/mL after 1 to 2 daysof treatment.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Child and Adolescent , Populations

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...